Literature DB >> 7733633

Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by adriamycin in the rat.

E Monti1, E Prosperi, R Supino, G Bottiroli.   

Abstract

The role of free radicals in the genesis of adriamycin (ADR)-induced delayed cardiotoxicity and the cardioprotective effects of the spin trap N-tert-butyl-alpha-phenylnitrone (PBN) were investigated in an in vivo rat model. As ADR and free radicals are no longer present in the myocardium by the time the delayed effects of the drug become apparent, ADR has been proposed to act by causing early radical-dependent DNA lesions, resulting in impaired synthesis of critical target proteins. DNA lesions were detected 10 days after ADR treatment (3X3 mg/kg i.v.) and were still present at the time of onset of the delayed cardiomyopathy. PBN, administered by a slow-release osmotic pump to maintain constant plasma levels throughout the time of persistence of ADR in the myocardium (approximately 2 weeks), prevented the development of DNA lesions, as well as the late contractile and electrical impairment induced by the anthracycline, thus supporting the hypothesis that free radicals play a causal role in both phenomena.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733633

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Molecular biology of doxorubicin-induced cardiomyopathy.

Authors:  J Umlauf; M Horký
Journal:  Exp Clin Cardiol       Date:  2002

2.  Effects of PPARα/PGC-1α on the energy metabolism remodeling and apoptosis in the doxorubicin induced mice cardiomyocytes in vitro.

Authors:  Yongyao Yang; Hongming Zhang; Xiaoyan Li; Tianhe Yang; Qingan Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 3.  Doxorubicin cardiomyopathy.

Authors:  Kanu Chatterjee; Jianqing Zhang; Norman Honbo; Joel S Karliner
Journal:  Cardiology       Date:  2009-12-11       Impact factor: 1.869

4.  A mouse model for juvenile doxorubicin-induced cardiac dysfunction.

Authors:  Wuqiang Zhu; Weinian Shou; R Mark Payne; Randall Caldwell; Loren J Field
Journal:  Pediatr Res       Date:  2008-11       Impact factor: 3.756

5.  Glutathione peroxidase 1-deficient mice are more susceptible to doxorubicin-induced cardiotoxicity.

Authors:  Jinping Gao; Ye Xiong; Ye-Shih Ho; Xuwan Liu; Chu Chang Chua; Xingshun Xu; Hong Wang; Ronald Hamdy; Balvin H L Chua
Journal:  Biochim Biophys Acta       Date:  2008-06-11

6.  Cardioprotective effect of methanolic extract of Ixora coccinea Linn. leaves on doxorubicin-induced cardiac toxicity in rats.

Authors:  Firoz N Momin; Bharatesh R Kalai; Tabassum S Shikalgar; Nilofar S Naikwade
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

Review 7.  Rodent models of cardiopulmonary disease: their potential applicability in studies of air pollutant susceptibility.

Authors:  U P Kodavanti; D L Costa; P A Bromberg
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

8.  Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.

Authors:  Rajarajan A Thandavarayan; Vijayasree V Giridharan; Somasundaram Arumugam; Kenji Suzuki; Kam Ming Ko; Prasanna Krishnamurthy; Kenichi Watanabe; Tetsuya Konishi
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

9.  HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.

Authors:  Yoichiro Otaki; Hiroki Takahashi; Tetsu Watanabe; Akira Funayama; Shunsuke Netsu; Yuki Honda; Taro Narumi; Shinpei Kadowaki; Hiromasa Hasegawa; Shintaro Honda; Takanori Arimoto; Tetsuro Shishido; Takuya Miyamoto; Hideaki Kamata; Osamu Nakajima; Isao Kubota
Journal:  J Am Heart Assoc       Date:  2016-01-21       Impact factor: 5.501

10.  Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2.

Authors:  Yintao Zhao; Jingjing Sun; Wei Zhang; Meng Peng; Jun Chen; Lu Zheng; Xiangqin Zhang; Haibo Yang; Yuan Liu
Journal:  Oxid Med Cell Longev       Date:  2020-08-01       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.